Published :
Report ID:
Pages :
Format :
The Global Anti-Aging Medicine Market Size Was Valued At USD 178.53 Billion In 2022, And Is Projected To Reach USD 310.41 Billion With CAGR Of 4.40% During The Forecast Period From 2022 To 2030.
{{info}}
On the global Anti-Aging Drugs Market, biotechnology companies are doing a lot more research to find ways to make drugs that can make people live longer. For example, Elevian, Inc. is studying a protein called "growth differentiation factor 11." (GDF11). When this protein was given to old mice, it was found to improve their brain function, make it easier for them to work out, and speed up the process of muscle repair.
Also, Elysium Health, a well-known company in the business of anti-aging, has come out with an over-the-counter supplement that aims to raise NAD+ levels, which will increase longevity genes. But no one knows what the clinical benefit of the supplement is. There are many different kinds of anti-aging drugs. There are a lot of different kinds of drugs. They could be the "fountain of youth" of the 21st century, like the "fountain of youth" was in the 16th century. The goal of their work is to help people live longer, healthier lives. This is done by slowing down or even stopping the process of aging.
Aging is caused by a series of biological processes that make the body weaker over time. This makes a person less healthy, fit, and attractive. Anti-aging is the process of stopping or slowing down these changes by using a variety of products and services. Today, a person's success depends on how good they look.
People's health all over the world has been affected in different ways because of the COVID-19 outbreak. People all over the world have to deal with a big social and economic burden because of the aftermath. People are going through a lot of mental trauma at the same time that policymakers are putting in place new frameworks and industries are using advanced models of growth to stay relevant.
The growing number of cases has caused mental and economic problems all over the world, especially among the elderly. Also, young people have been having trouble because they've lost their jobs, so they're turning to family care to deal with the effects. Most of the attention is on treating COVID-19 and making a vaccine, which takes the spotlight off of other markets. But people who want to stay healthy are buying a lot more natural products that are made from healthy ingredients. In the long run, this should be very good for the business of anti-aging drugs.
Market Trends:
The market will grow because more and more people are getting older.
The world's elderly population is growing quickly and strongly, which opens up a wide range of possibilities for the development of anti-aging drugs. The growing number of older people is a target market for anti-aging drugs, which helps the market move forward. The World Health Organization (WHO) predicts that the number of people over 60 will double by 2050, going from 12 percent in 2015 to 22 percent in 2050.
Also, as the lifestyle and fashion industries have become more important, the desire among older people to stay young and healthy has grown. Also, because of higher standards of beauty, people of all ages are becoming more interested in anti-aging drugs. So, older people are more likely to use anti-aging products, and this increased awareness is going to cause the anti-aging drugs market to grow a lot in the next few years.
Driving Factors:
The global anti-aging products market is being driven by the fact that younger people are becoming more aware of body and skin anti-aging products. People are more likely to take care of their skin because skin problems are getting worse due to pollution, bad eating habits, drinking too much alcohol, etc. Anti-aging products like creams, lotions, gels, etc. are becoming more popular because more and more people want to look young and healthy. Many people choose different skin care treatments and cosmetic procedures to make their skin look better, reduce pigmentation and damage from UV rays, and so on. The market is growing because more and more people are getting older and more companies are entering the global anti-aging market to provide new ways to treat skin problems.
Adding organic products to the market for anti-aging products is also expected to be a major growth driver for the market. People were worried about using anti-aging products because they had a number of bad effects. Some people also get too many wrinkles, acne, and other problems from using these products, which makes them hard to use. On the global market for anti-aging products, there has been a huge increase in demand for organic anti-aging products.
Restraints/Challenges:
When people's buying power goes up, they will be more likely to buy branded products. People are moving toward high-quality products because of advertising and changes in their lifestyles. The anti-aging market in the Asia-Pacific region has a big chance to grow if people can spend more money.
Price increases have caused companies to cut their profit margins and raise the prices of their products. This is one of the main things holding back the growth of the anti-aging market around the world. But this is only a short-term problem that is expected to be solved soon. Most companies plan to open subsidiaries to get their raw materials so they don't have to worry about costs like this. So, we expect this constraint to have a moderate effect during the forecast period.
Opportunities:
In the future, anti-aging drugs will be made better by manipulating genes, using more embryonic and adult stem cells, and using nanotechnology to deliver nutrients and drugs to specific parts of the body. Advanced anti-aging drug technologies focused on finding diseases related to aging early, preventing them, and treating them. So, a new drug in development might be able to treat a wide range of age-related diseases and make anti-aging products work better and be safer. This is making the market for anti-aging drugs grow. The market is growing because people are becoming more aware of the signs of aging, the number of overweight people is rising, and people are spending more time sitting down.
Top market players are
The company Pfizer Inc. (Pfizer) finds, develops, makes, and sells biopharmaceuticals. The company sells products to treat heart, metabolic, and pain diseases, as well as cancer, inflammation, immune disorders, and rare diseases. It also sells sterile injectable drugs, biosimilars, active pharmaceutical ingredients (APIs), and contract manufacturing services.
Travador is a luxury travel company that focuses on short trips and events. The company makes personalized travel deals for customers, like trips to sold-out concerts and sports games, wellness weekends, and more, at the best price possible.
Himalaya Drug Company is an Indian multinational pharmaceutical company started by Mohammed Manal in 1930 and based in Bengaluru, Karnataka, India. It makes health care products with ayurvedic ingredients under the name Himalaya Herbal Healthcare.
Cipla Limited makes and sells medicines and products for personal care. The company sells active pharmaceutical ingredients and formulations in therapeutic areas like allergy, analgesic, anti-malarial, anti-infectives, cardiology, dermatology and cosmeceuticals, diabetology, gastroenterology, steroids, iron chelators, and nutritional products.
Mylan Laboratories Limited is a company that makes medicines. The company works on developing and making solid oral dosage forms, bulk actives, and intermediates. Mylan Laboratories sends its products all over the world.
Novartis AG is a holding company that develops, makes, and sells medicines and other health products. It has three business units that make it work: Innovative Medicines, Sandoz, and Corporate.
Merck KGaA, which is owned by E. Merck KG and goes by the name "Merck," is a science and technology company. It finds, develops, and makes prescription drugs to treat cancer, multiple sclerosis, and infertility. It also makes liquid crystal mixtures, organic light-emitting diode (OLED) materials, cosmetic active ingredients, coating pigments, and high-tech materials.
Vitabiotics Ltd. makes products for health care. The company makes, sells, and ships vitamin supplements, nutritious foods and drinks, patented pharmaceutical products, and pharmaceutical products with special functions.
William Ransom & Son plc is a company based in the United Kingdom. It sells branded natural health products, vitamins, and food supplements. It also makes pharmaceutical products and extracts plant material for the pharmaceutical, food, and beverage industries.
In 1985, Uni-Vite Japan Ltd. was set up. The Company's main business is selling specialty foods like eggs, poultry, health foods, spices, herbs, coffee, and tea to customers in stores.
Health Made Easy Limited is an administration company that was founded on September 27, 2015, in Birmingham, West Midlands, where its registered office is also located. Since 2004, Health Made Easy Limited has been in business.
The market is segmented on the basis of type, treatment, application and regions.
By Type Outlook:
The market is divided into Anti-wrinkle Products, Anti-stretch Mark Products, Hair Color Products, and Other Products, based on the type of product. Products that prevent stretch marks and wrinkles are expected to grow a lot over the next few years. Stretch marks show up when the skin grows or shrinks quickly. Because of the sudden change, the collagen and elastin that hold the skin together broke. Stretch marks are mostly caused by getting older. Most people get stretch marks when they lose or gain weight quickly or when they are pregnant. The category is expected to grow because people are getting fatter, especially older people, which is driving up demand for anti-stretch mark products. Also, major players are putting more effort into releasing new equipment and products to treat stretch marks, which is expected to help the category grow.
By Treatment:
The market is divided into Hair Restoration, Anti-Pigmentation, Adult Acne Therapy, Breast Augmentation, Liposuction, and Chemical Peel based on the treatment. The anti-aging market will grow most quickly in the area of hair restoration therapies.
By Application Outlook:
Based on how they are used, the anti-aging drugs market is divided into skin and hair, bones and muscles, age-related disorders, and others. In 2022, most of the money made from the anti-aging drugs market came from the skin and hair segment. This is because people are becoming more interested in how well routines and habits work, which is driving up demand for health-promoting and self-care products. Also, in 2021, skin care was number one and made up about 41% of the global market. About 16% of the money was spent on beauty products and 22% on hair care. Skincare is expected to bring in 188 billion dollars in sales by 2026, making it one of the most profitable types of products. As of 2021, North Asia was responsible for about 35% of the business.
Geographically, the global market for anti-aging medicines has been looked at in North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa (MEA).
{{info2}}
The North American anti-aging medicine market is expected to have the biggest share of the global anti-aging medicine market in terms of revenue. This is because North Americans spend more on health care and there are more manufacturers in North America.
During the forecast period, Europe is expected to have the second largest share of the global anti-aging medicines market. This is because the number of older people is growing and people are spending more on health care products and supplements. Due to a lack of manufacturers and low healthcare spending, the MEA anti-aging medicine market is expected to grow slowly over the next few years.
During the forecast period, the global anti-aging medicines market is expected to grow at the highest CAGR in Asia Pacific. This is because demand from end users is growing and major players are moving into the region.
Report Attribute | Details |
Study Period | 2017-2030 |
Base Year | 2022 |
Estimated year | 2023 |
Forecast period | 2023-2030 |
Historic Period | 2017-2022 |
Units | Value (USD Billion) |
Growth Rate | CAGR of 4.40% from 2023 to 2030 |
By Type |
|
By Treatment |
|
By Application |
|
By Companies |
|
Regional Scope |
|
Reasons to Purchase this Report and Customization Scope |
|